We would like to thank the following people for their assistance with the planning, execution, and analysis of this study: Terri Hyde, Kashmira Date, Nadia Jean-Charles Lapierre, Patrick Dely, Kristen Mertz, Melissa Etheart, Carisma Atkins, and Melissa Latigo.
Ministere de la Sante Publique et de la Population, 2016. Rapport Cholera du jour par Department. Available at: http://mspp.gouv.ht/site/downloads/Rapport%20cholera%20revise%201er%20decembre%202016.pdf. Accessed December 14, 2016.
Ministry of Public Health and Population, 2013. National Plan for the Elimination of Cholera in Haiti 2013–2022. Available at: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=20326&Itemid=270&lang=en. Accessed July 22, 2014.
Sur D., 2011. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 5: e1289.
Wierzba TF., 2015. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha state, India. Vaccine 33: 2463–2469.
Bhattacharya SK., 2013. Five-year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomized, double-blind, placebo-controlled trial. Lancet Infect Dis 13: 1011.
Barzilay EJ, Schaad N, Magloire R, Mung KS, Boncy J, Dahourou GA, Mintz ED, Steenland MW, Vertefeuille JF, Tappero JW, 2013. Cholera surveillance during the Haiti epidemic—the first two years. N Engl J Med 368: 599–609.
CDC, 2012. SurvCost: Estimating the Cost of Surveillance. Atlanta, GA: CDC. Available at: https://www.cdc.gov/globalhealth/healthprotection/idsr/resources.html. Accessed August 2, 2017.
Oral cholera vaccines in mass immunization campaigns: guidance for planning and use - Addendum. World Health Organization, 2010. ISBN 978 92 4 150043 2. http://www.who.int/cholera/vaccines/AddendumGuideVaccinationForShanchol050913.pdf. Accessed August 2, 2017.
Tohme RA., 2015. Oral cholera vaccine coverage, barriers to vaccination, and adverse events following vaccination, Haiti, 2013. Emerg Infect Dis 21: 984–991.
Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B, 1999. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ 77: 837–842.
Schaetti C, Weiss MG, Ali SM, Chaignat CL, Khatib AM, Reyburn R, Duintjer Tebbins RJ, Hutubessy R, 2012. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar. PLoS Negl Trop Dis 6: e1844.
Cavailler P., 2006. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine 24: 4890–4895.
Khan IA., 2013. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Vaccine 31: 6058–6064.
Kar SK., 2014. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model. PLoS Negl Trop Dis 8: e2629.
Severe K, Rouzier V, Anglade SB, Bertil C, Joseph P, Deroncelay A, Mabou MM, Wright PF, Guillaume FD, Pape JW, 2016. Effectiveness of oral cholera vaccine in Haiti: 37-month follow-up. Am J Trop Med Hyg 94: 1136–1142.
Farmer P., 2011. Meeting cholera’s challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis 5: e1145.